IRF-4 Activators encompasses a diverse group of compounds that indirectly influence the activation of the transcription factor IRF-4. These chemicals interact with various signaling pathways and cellular processes, leading to the modulation of IRF-4 activity. Some IRF-4 activators can modulate NF-κB signaling, a pathway that has crosstalk with IRF-4 regulatory mechanisms, thereby influencing IRF-4's activity in the context of immune responses.
Other compounds exert their effects by inhibiting key enzymes or signaling molecules in T cell activation and differentiation pathways, which are known to involve IRF-4. Specific kinase inhibitors alter cellular signaling in response to stress and inflammation, with downstream effects on IRF-4 activation. These chemicals can impact the activity or expression of IRF-4 by altering the cellular context or the signaling milieu, thereby indirectlymodulating IRF-4's role in gene regulation. Each of these chemicals interacts with complex intracellular signaling cascades, leading to varied effects on IRF-4 activity.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that can alter the signaling pathways involved in the activation of IRF-4 in response to stress signals. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates stress-activated protein kinases (SAPKs), which can modulate transcription factors, including IRF-4, in response to stress signals. | ||||||